Many HUMIRA-treated patients experienced significant inhibition of radiographic progression at week 48 vs week 24 of placebo.1,2
Signs and symptoms
Most HUMIRA-treated patients saw significant improvement in signs and symptoms at week 12 vs placebo.1,3
Many HUMIRA-treated patients saw significant improvement in physical function at week 12 vs placebo.1
Clinically studied safety data
Well-studied safety profile in clinical trials.1,5,6
†HUMIRA Citrate-free is available to all indicated patients in the United States. HUMIRA Citrate-free features the same safety and efficacy profile of HUMIRA you've come to count on.
§Injection site pain immediately following injection as measured using a 0-10 cm Visual Analog Scale: HUMIRA 40 mg/0.4 mL vs HUMIRA 40 mg/0.8 mL.